AMBRA1 and neoplasm: Despite the faster growth kinetics of Ambra1-deficient tumors, the proliferation rate of BPA−/− mice analyzed at the final endpoint (i.e., after 42 days, when maximum tolerated tumor size was reached) appeared slightly, but significantly, decreased (Fig. 2a, b).